Document Detail


Does the C34T mutation in AMPD1 alter exercise capacity in the elderly?
MedLine Citation:
PMID:  16767606     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Ageing does affect functional capacity through several changes at the peripheral muscle level that impair the muscles capacity to produce energy and generate force. The skeletal muscle-specific isoform of AMP deaminase (AMPD) plays an important regulatory role in muscle metabolism and in determining energy charge. Since nearly 20 % of the general Caucasian population is heterozygous (CT) for the most common C34T mutation of the gene (AMPD1) encoding for this enzyme, it would be worthwhile to study if such a condition further increases the effects of ageing. Twenty-one women (61 - 80 yrs) served as subjects, and depending on the results of previous genotyping, were assigned to a group with the C34T mutation (heterozygous; n=4; mean+/-SEM age: 71+/-1 yrs) or with no mutation (n=17; 68+/-1 yrs). Several indices of maximal (peak oxygen uptake [V.O (2 peak)], peak power output) and submaximal endurance performance (ventilatory threshold, mechanical efficiency) and functional tests (one-mile walk test and a specific test of lower-body functional performance [sit-stand test]) were compared between the two groups. No significant differences were found in exercise capacity between both groups, e. g. V.O (2 peak) of 19.1+/-1.0 vs. 20.1+/-1.9 ml . kg (-1) . min (-1), V.O (2) at the VT of 11.9+/-0.6 vs. 12.9+/-1.0 ml . kg (-1) . min (-1), or time to complete the one-mile walk test (951+/-18 s vs. 962+/-61 s) and sit-stand test (9.9+/-0.2 vs. 9.2+/-0.2) (no mutation vs. C34T mutation, respectively). Although more research is necessary, it seems that the C34T mutation of the AMPD1, at least in heterozygous individuals, does not affect functional capacity in the elderly.
Authors:
M Pérez; M A Martin; S Cañete; J C Rubio; D Fernández-Moreira; A F San Juan; F Gómez-Gallego; C Santiago; J Arenas; A Lucia
Related Documents :
7610866 - Comparative study on gait abnormality in patients with vestibular neuronitis and patien...
19629846 - Decrease in heart rate after longitudinal participation in the groningen active living ...
19165696 - How humans walk: bout duration, steps per bout, and rest duration.
2375676 - Energy consumption in paraplegic ambulation using the reciprocating gait orthosis and e...
9692436 - Retrograde cerebral perfusion enhances cerebral protection during prolonged hypothermic...
19127706 - Inflammatory and oxidative and nitrosative stress pathways underpinning chronic fatigue...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  International journal of sports medicine     Volume:  27     ISSN:  0172-4622     ISO Abbreviation:  Int J Sports Med     Publication Date:  2006 Jun 
Date Detail:
Created Date:  2006-06-12     Completed Date:  2006-11-21     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8008349     Medline TA:  Int J Sports Med     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  429-35     Citation Subset:  IM    
Affiliation:
Universidad Europea de Madrid, Madrid, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
AMP Deaminase / genetics*
Aged
Aged, 80 and over
Exercise Test
Exercise Tolerance / genetics*
Female
Humans
Lactic Acid / blood
Middle Aged
Mutation*
Oxygen Consumption / genetics
Physical Endurance / genetics
Pulmonary Gas Exchange
Chemical
Reg. No./Substance:
50-21-5/Lactic Acid; EC 3.5.4.6/AMP Deaminase; EC 3.5.4.6/AMPD1 protein, human

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Chronic ischemic gastritis: case report of a difficult diagnosis and review of the literature.
Next Document:  Lactate distribution in the blood compartments of sickle cell trait carriers during incremental exer...